Sara Svardgren
Oficial de Recursos Humanos en ONCOPEPTIDES AB .
Origen de la red de primer grado Sara Svardgren.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Sara Svardgren a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| CELGENE | Biotechnology | Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MEDIVIR AB | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| RAYSEARCH LABORATORIES AB | Packaged Software | Director of Finance/CFO Director of Finance/CFO | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Director/Board Member General Counsel | |
Industrifonden
 Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Private Equity Investor | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
Takeda Corp.
 Takeda Corp. Pharmaceuticals: MajorHealth Technology Takeda Corp. manufactures and distributes pharmaceutical products. The company is headquartered in Tokyo, Japan | Pharmaceuticals: Major | Corporate Officer/Principal | |
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Investor Relations Contact | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin | |
| University of Uppsala | College/University | Graduate Degree Doctorate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| University of Stockholm | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Graduate Degree | |
| CAMURUS AB | Pharmaceuticals: Major | Director/Board Member Investor Relations Contact | |
| University of Westminster | College/University | Masters Business Admin | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Gothenburg | College/University | Doctorate Degree Undergraduate Degree | |
| Pfizer NV/SA | Corporate Officer/Principal | ||
| Pfizer AB | Corporate Officer/Principal Public Communications Contact | ||
| CANTARGIA AB | Pharmaceuticals: Major | Director/Board Member | |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Director/Board Member | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Investor Relations Contact Director of Finance/CFO Investor Relations Contact General Counsel General Counsel | |
| BIOVICA INTERNATIONAL AB | Biotechnology | Director/Board Member | |
| ISOFOL MEDICAL AB | Pharmaceuticals: Major | Chief Executive Officer | |
| Mesothelioma Applied Research Foundation, Inc. | Director/Board Member | ||
| SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member | |
| GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Director/Board Member | |
Monocl AB
 Monocl AB Internet Software/ServicesTechnology Services Monocl AB develops cloud-based stakeholder platform. Its areas include business development, valuation, and communication. The company was founded by Björn Carlsson and Tobias Thornblad in 2011 and is headquartered in Gothenburg, Sweden. | Internet Software/Services | Director/Board Member | |
OnTarget Chemistry AB
 OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Biotechnology | Chief Executive Officer | |
| Trygga Pengar I Mobilen Sverige AB | Director/Board Member | ||
| Lesvensson Snickeri AB | Director/Board Member | ||
Immuneed AB
 Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
| Hw Svenskt Reklamscreen AB | Director/Board Member | ||
| Oncopeptides Incentive AB | Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Director/Board Member | ||
| Healthcom GmbH | Corporate Officer/Principal | ||
OT Lehmann Holding AB
 OT Lehmann Holding AB Investment Banks/BrokersFinance OT Lehmann Holding AB provides securities and property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Recipharm OT Chemistry AB
 Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Synartro AB | Chairman | ||
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Medical/Nursing Services | Director of Finance/CFO | |
| OT Pharmaceuticals AB | Chief Executive Officer | ||
Oncopeptides, Inc.
 Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Part of Oncopeptides AB, Oncopeptides, Inc. is a company committed to developing therapies for difficult-to-treat hematological diseases. The company is based in Waltham, MA. Oncopeptides strives to bring hope to patients through science and innovation, and is dedicated to bringing forward new and meaningful treatment options. The company is inspired by the perseverance of patients, caregivers, and healthcare providers in their fight against cancer. Oncopeptides' focus is on the development of therapies that can make a difference in the lives of those affected by hematological diseases. | Medical/Nursing Services | Chairman Director/Board Member | |
AnaCardio AB
 AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Suecia | 36 |
| Estados Unidos | 9 |
| Japón | 2 |
| Alemania | 2 |
| Reino Unido | 2 |
Sectorial
| Health Technology | 26 |
| Consumer Services | 7 |
| Health Services | 4 |
| Technology Services | 3 |
| Commercial Services | 3 |
Operativa
| Director/Board Member | 137 |
| Corporate Officer/Principal | 62 |
| Director of Finance/CFO | 32 |
| Independent Dir/Board Member | 32 |
| Chief Executive Officer | 26 |
Las relaciones más conectadas
- Bolsa de valores
- Insiders
- Sara Svardgren
- Conexiones Empresas
